BridgeMD
New treatment option for Consciousness, Level Altered
Official title The Electroencephalographic Mechanisms of Anesthesia and Human Consciousness
ClinicalTrials.gov ID: NCT07145697
What this study is testing
What is Dexmedetomidine?
Dexmedetomidine is an investigational medicine, being studied as a potential treatment for consciousness, level altered.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- In the field of general anesthesia research, the neural mechanism underlying the loss of consciousness has long been a highly core issue. It remains unclear what consciousness is and how it emerges from brain activity.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 65
You may be able to join if
- Age range: 1 - 65 years old
- BMI: 18.5 - 25.0 kg/m²
- ASA physical status classification: I - III
- Patients diagnosed with drug - refractory epilepsy who, after long - term monitoring of epileptic seizures, require stereo-electroencephalography...
- Patients voluntarily participate in this study and sign a written informed consent form.
You likely can't join if
- Patients with severe arrhythmia or other organic heart diseases;
- Patients with comorbid obstructive sleep apnea-hypopnea syndrome (OSAHS);
- Patients with hepatic or renal dysfunction; those with a history of immunodeficiency diseases , or a history of cancer/malignant tumors, or a history...
- Patients with any history of diseases that may affect protocol compliance (such as severe mental disorders, disturbance of consciousness; cognitive...
- Pregnant or lactating women, or those of childbearing potential who are unwilling/unable to take effective contraceptive measures;
- Patients with known allergies to the ingredients contained in the drugs used in this study;
See the full eligibility criteria
- Age range: 1 - 65 years old
- BMI: 18.5 - 25.0 kg/m²
- ASA physical status classification: I - III
- Patients diagnosed with drug - refractory epilepsy who, after long - term monitoring of epileptic seizures, require stereo-electroencephalography (SEEG) electrode implantation based on the clinical need for monitoring...
- Patients voluntarily participate in this study and sign a written informed consent form.
- Patients with severe arrhythmia or other organic heart diseases;
- Patients with comorbid obstructive sleep apnea-hypopnea syndrome (OSAHS);
- Patients with hepatic or renal dysfunction; those with a history of immunodeficiency diseases , or a history of cancer/malignant tumors, or a history of autoimmune diseases, or severe cardiovascular and cerebrovascular...
- Patients with any history of diseases that may affect protocol compliance (such as severe mental disorders, disturbance of consciousness; cognitive dysfunction, drug abuse or addiction, etc.);
- Pregnant or lactating women, or those of childbearing potential who are unwilling/unable to take effective contraceptive measures;
- Patients with known allergies to the ingredients contained in the drugs used in this study;
- Patients who have participated in any drug clinical trial within 6 months before the screening examination;
- Patients who are deemed unsuitable to participate in this study by the researcher.
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.